Travel Vaccines Market Set To Witness Adamant Revenue Growth of US$ 5,914.22at CAGR 9.8% in 2028

Travel vaccines, also called travel immunizations, are shots travelers can get before visiting certain areas of the world, which help protect them from serious illnesses common in those ahead. Travel vaccines are safe, effective ways to help protect travelers from bringing home more infections than expected. These vaccines are recommended to provide protection against diseases endemic to the country of origin or of destination. They are intended to protect travelers and to prevent disease spread within and between countries. Some countries require proof of vaccination for travelers wishing to enter or exit the country. The rapid growth of the travel and tourism sector, and the rising incidence of infectious diseases contribute to the market progress. However, the high cost of travel vaccines hinders the market growth.

The Travel Vaccines Market is expected to grow from US$ 3,078.94 million in 2021 to US$ 5,914.22 million by 2028; it is estimated to grow at a CAGR of 9.8% during 2021-2028.

The Travel Vaccines market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, seg ment, and company are documented as well.

List of Companies operating in this report are:
• GlaxoSmithKline plc
• Merck & Co., Inc.
• Sanofi
• Novartis AG
• Pfizer Inc.
• Dynavax Technologies
• Emergent BioSolutions Inc.
• Abbott
• Bharat Biotech
• Valneva SE.

Get Sample PDF Copy of Travel Vaccines Market at:
https://www.theinsightpartners.com/sample/TIPRE00007439/?utm_source=OpenPR&utm_medium=10411

Furthermore, the market is segmented based on type, application, and region in order to study it exhaustively and provide the data in a systematic manner. Speaking of competitive landscape, the study includes a list of leading companies along with their product and service offerings, strategic decisions, SWOT analysis, latest developments, market share captured, growth rate, and valuation. The challenges faced by these companies are analyzed and solutions for them are given as well.

Market Segmentation:
The travel vaccines market, by sequencing, is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. The others segment held the largest share of the market in 2021. However, the meningococcal vaccines segment is anticipated to register the highest CAGR in the market during the forecast period. The market growth for other segment is attributed to the increasing incidences of preventable diseases such as typhoid, yellow fever, rabies, Japanese encephalitis (JE), DPT, influenza, measles, mumps, and varicella .

Growing Incidences of Infectious Diseases Fuels Travel Vaccines Market Growth:
Hepatitis, HIV/AIDS, human papillomavirus (HPV), meningococcal disease, typhoid, and yellow fever are among the various chronic diseases detected across the world. According to the World Health Organization (WHO), it ~500 million people are estimated to get infected by hepatitis B or C. Hepatitis B and C viruses are deadly and have the potential to kill ~1.5 million people in a year. Across the world, 1 in every 3 persons is infected by hepatitis B or C or both; most people are unaware of the infection due to their dormant symptoms. However, hepatitis is preventable through vaccination, owing to which various organizations are proposing strategies to prevent premature deaths from hepatitis. As per the WHO estimates, 4.5 million deaths can be prevented in low- and middle-income countries by 2030. WHO Member States are endorsing the global hepatitis strategy of the WHO to reduce infections by 90% and deaths by 65% by 2030.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Travel Vaccines market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

Have Question? Speak to Analyst at:
https://www.theinsightpartners.com/speak-to-analyst/TIPRE00007439/?utm_source=OpenPR&utm_medium=10411

Several market forces such as drivers and restraints and political, social, economic and technological advancements help shape up the industry in specific manner. All such forces are studied in detail to arrive at a market forecast which can help build the investment strategies in Travel Vaccines market.

Essential points covered in Travel Vaccines market report are:-
1 What will the market size and the growth rate be in 2028?
2 What are the key growth stimulants of Travel Vaccines market?
3 What are the key market trends impacting Travel Vaccines market valuation?
4 What are the challenges to market proliferation?
5 Who are the key vendors in the Travel Vaccines market?
6 Which are the leading companies contributing to Travel Vaccines market valuation?
7 What was the market share held by each region in 2028?
8 What is the estimated growth rate and valuation of Travel Vaccines market in 2028?

Order a Copy of Travel Vaccines Market Share, Strategies and Forecasts 2021-2028 Research Report at:
https://www.theinsightpartners.com/buy/TIPRE00007439/?utm_source=OpenPR&utm_medium=10411

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.